19 September 2023
Short peptides derived from anti-inflammatory ‘evasins’ released by ticks could be used to develop new treatments for anti-inflammatory disease.
31 August 2023
The three students all spent seven weeks working alongside BHF CRE researchers on diverse cardiovascular projects.
31 July 2023
Congratulations to Associate Professor Duncan Sparrow on his appointment as Supernumerary Fellow of Exeter College, University of Oxford.
14 July 2023
As part of the British Heart Foundation (BHF) Heart Heroes Awards, the CureHeart project has been shortlisted for the BHF Media Award 2023 – Research Story of the Year.
22 June 2023
On Sunday 18 June 2023, a team of researchers based at the Institute of Developmental and Regenerative Medicine (IDRM) took on the British Heart Foundation’s (BHF) London to Brighton Bike Ride, raising more than £1300 and counting.
BHF Fellowship extension for Lisa Heather to further our understanding of metabolic dysfunction in diabetes
16 June 2023
Congratulations are in order for Associate Professor Lisa Heather, who has been awarded an extension of her British Heart Foundation Intermediate Basic Science Research Fellowship. The extension recognises her successful research on the impact of abnormal metabolism in diabetes on the heart and will prepare her for progression to a Senior Fellowship.
13 June 2023
Professor David Paterson, in collaboration with the UCLA’s Professor Kalyanam Shivkumar, has been awarded a prestigious Leducq International Network of Excellence Program Award of $8 million (£6.3M) to set up a major new transatlantic network linking world leading researchers from the USA and Europe to develop ‘Bioelectronics for neurocardiology diagnosis and therapeutics’.
BHF Fellowship renewal for Sarah De Val paves the way to novel strategies for inducing and improving arterial growth
5 June 2023
Congratulations are in order for Associate Professor Sarah De Val, who has been awarded a renewal of her British Heart Foundation Senior Basic Science Research Fellowship. The award recognises her pioneering research on coronary vessel formation and differentiation.
2 June 2023
An exciting new collaborative study from RDM and DPAG researchers has found that fat metabolism could be the key to tackling heart failure.
2 June 2023
Congratulations are in order to Professor Manuela Zaccolo on being awarded Membership of the Academia Europaea (MAE).
24 April 2023
Oxford BHF CRE Senior Leadership Team member, Professor Casadei, has been awarded the prestigious Louis and Artur Lucian Award.
17 April 2023
Congratulations are in order to BHF CRE Senior Leadership Team member Professor Manuela Zaccolo, who has been elected Fellow of the Istituto Veneto di Scienze, Lettere ed Arti, one of the most prestigious Academies in Italy.
14 April 2023
Professor Tzima, part of the Oxford BHF CRE's Senior Leadership Team, has been awarded the prestigious 2024 Biochemical Society GlaxoSmithKline award
Clinical trial investigating potential investigational treatment for relief of fatigue in people with long COVID reports results
14 April 2023
Research led by Associate Professor Betty Raman finds positive results from a Phase 2 clinical trial of an investigational treatment against long COVID fatigue.
24 March 2023
Claire Aitken, from the Tzima lab, will compete at the Women's Blue Boat Race this Sunday
9 March 2023
A new Zaccolo group study has revealed key new insights into the role of cAMP signalling in both healthy and disease settings within the heart. They have identified new cAMP nanodomains in cardiac muscle cells that have far reaching implications for the treatment of heart disease.
7 February 2023
A new publication from the ongoing OxAMI study finds that patients who have had a heart attack show subtle inflammatory differences in the heart muscle unaffected by heart attack. These differences are linked to patients' long-term prognosis.
31 January 2023
Researchers from the Herring group have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.
24 January 2023
Researchers at Oxford Population Health and King’s College London have found that people with high levels of some triglyceride-carrying apolipoproteins may still be two to three times more likely to develop coronary heart disease even if their LDL-cholesterol levels are under control. The results are published in Circulation Research.